W elcome to Lolo’s Angels. Lolo’s Angels, Inc.’s mission is to fund life-saving research for pediatric Acute Myelocytic Leukemia (AML), sponsor blood and bone marrow drives, and raise awareness for pediatric cancer.
Lolo’s Angels, Inc. is a 501c3 non-profit.
Donations are tax-deductible.
The Story Behind Lolo’s Angels, Inc.
It will help you understand our resolve and our direction. This can make a difference and give kids a chance. Please help us!
Thank you to everyone who made our 2nd Annual Backyard Bash a Success!
Thank you to everyone helping us meet our goal!
We are making progress but we can still use more help.
Your donations help Lolo's Angels Inc fund life saving research for pediatric Acute Myelocytic Leukemia (AML), sponsor blood and bone marrow drives, and raise awareness for pediatric cancer.
Please consider donating today. Every single dollar helps!
Our Goal for 2017.......... $25,000
Our Current Progress......$32,000
Thank you helping us exceed our Goal!
Please take the time to view this video from Target Pediatric AML
Target AML - Overview video
AML is one of the poorest prognosis pediatric cancers. Help us accelerate a key research initiative to speed personalized, precision therapies to desperate infants, kids, teens and young adult patients ages 0-35. Over 80% of AML cases are diagnosed in adults over 60, so most research is focused in seniors. But, AML is biologically different in younger patients. The TpAML initiative is the Children's Oncology Group's "highest potential and greatest need" AML research project. The goal is to understand the drivers and vulnerabilities of this devastating leukemia in young people leveraging the power of genomic sequencing. Check out our video, learn more and get involved -- https://cog-foundation.networkforgood.com/projects/18979-target-pediatric-aml > The Children's Oncology Group is the world's largest organization dedicated to pediatric cancer research > TpAML is a volunteer-run, grassroots effort to inform and encourage collaboration among friends, families and foundations of all sizes, nationwide, to speed this promising discovery work (contact us with questions!)Posted by target pediatric AML on Monday, January 23, 2017